The Annual report of the Australian Meningococcal Surveillance Programme, 2001
DOI:
https://doi.org/10.33321/cdi.2002.26.33Keywords:
antibiotic resistance, meningococcal disease, Neisseria meningiditisAbstract
Since 1994, the National Neisseria Network has examined and analysed isolates of Neisseria meningitidis from cases of invasive meningococcal disease in Australia by means of a collaborative laboratory program. The phenotypes (serogroup, serotype and serosubtype) and antibiotic susceptibility of 338 isolates of N. meningitidis from invasive cases of meningococcal disease were determined in 2001. Most disease was caused by serogroup B (206 isolates, 61%) or serogroup C (122 isolates, 36%) meningococci. However, there was considerable diversity in the phenotypes circulating in the different states and territories. Serogroup B strains predominated in all jurisdictions except Victoria and Tasmania and were isolated from sporadic cases of invasive disease. Serogroup B phenotypes were generally disparate with phenotype B:4:P1.4 being the most common and phenotype B:15:P1.7 was also widely distributed. Infections with a novel phenotype that was first noted in 1999, C:2a:P1.4(7), were again common in Victoria, especially in adolescents and adults, but were infrequently seen elsewhere in Australia. In Tasmania, a different phenotype, C:2a:P1.5,2 accounted for 11 of 16 isolates, again predominantly in infections of young adults. The number of isolates in Queensland increased to 78 from 43 in 2000 and was due to more strains of both serogroup B and serogroup C meningococci. About two-thirds of all isolates showed decreased susceptibility to the penicillin group of antibiotics (MIC 0.06 to 0.5 mg/L). All isolates tested were susceptible to third generation cephalosporins. From 1999, reports have also included diagnoses made by non-culture based methods in these analyses. Data relating to 135 laboratory-confirmed but culture negative cases supplemented information on culture-confirmed cases in this report. Commun Dis Intell 2002;26:407-418.
Downloads
References
National Neisseria Network. Meningococcal Isolate Surveillance Australia 1994. Commun Dis Intell 1995;19:286-289.
National Neisseria Network. Meningococcal Isolate Surveillance Australia 1995. Commun Dis Intell 1996;20:422-424.
The Australian Meningococcal Surveillance Programme. Annual report of the Australian Meningococcal Surveillance Programme 1996. Commun Dis Intell 1997;21:217-221.
Australian Meningococcal Surveillance Programme. Annual report of the Australian Meningococcal Surveillance Programme 1997. Commun Dis Intell 1998;22:205-211.
The Australian Meningococcal Surveillance Programme. Annual report of the Australian Meningococcal Surveillance Programme, 1998. Commun Dis Intell 1999;23:317-323.
Australian Meningococcal Surveillance Programme. Annual report of the Australian Meningococcal Surveillance Programme, 1999. Commun Dis Intell 2000;24:181-189.
The Australian Meningococcal Surveillance Programme. Annual report of the Australian Meningococcal Surveillance Programme, 2000. Commun Dis Intell 2001;25:113-121.
The Australian Gonococcal Surveillance Programme. Penicillin sensitivity of gonococci in Australia: development of an Australian Gonococcal Surveillance Programme. Br J Vener Dis 1984;60:226-230.
Porritt RJ, Mercer JL, Munro R. Detection and serogroup determination of Neisseria meningitidis in CSF by polymerase chain reaction (PCR). Pathology 2000;32:42-45.
Gray SJ, Borrow R, Kaczmarski EB. Meningococcal serology. In: Pollard AJ, Martin MCJ, eds. Meningococcal disease methods and protocols. Humana Press, Totawa, New Jersey, 2001:61-87.
Robertson PW, Reinbott P, Duffy Y, Binotto E, Tapsall JW. Confirmation of invasive meningococcal disease by single point estimation of IgM antibody to outer membrane protein of Neisseria meningitidis. Pathology 2001;33:375-378.
Taha M-K. Molecular detection and characterization of Neisseria meningitidis. Expert Rev Mol Diagn 2002;2:143-150.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2002 Communicable Diseases Intelligence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
